Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up

समान संसाधन

• Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
  द्वारा: Martini A, और अन्य
  प्रकाशित: (2011-09-01)
• National CAPS (Cryopyrin-Associated Periodic Syndrome) Registry
  द्वारा: Bibalo, C, और अन्य
  प्रकाशित: (2011)
• The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age
  द्वारा: Caorsi, Roberta, और अन्य
  प्रकाशित: (2013)
• An experience of use of canakinumab IL-1 inhibitor in children with cryopyrin-associated periodic syndromes (CAPS)
  द्वारा: Salugina, Svetlana O, और अन्य
  प्रकाशित: (2014)
• Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients
  द्वारा: Bader-Meunier, B, और अन्य
  प्रकाशित: (2011)